The Patent Finder

Ophidian Pharmaceuticals, Inc.

Also on record
Records under this name other than patents Ophidian Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Ophidian Pharmaceuticals, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,967,088Soluble recombinant botulinum toxin proteins
Formerly held
Lapsed on the fee record
Ended Nov 22, 2013 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2013USPTO record
US 6,290,960Vaccine and antitoxin for the treatment of C. difficile disease
Formerly held
Lapsed on the fee record
Ended Sep 18, 2013 · USPTO record
Lapsed on the fee recordEnded Sep 18, 2013USPTO record
US 6,214,343Prevention and treatment of necrotizing enterocolitis
Formerly held
Lapsed on the fee record
Ended Apr 10, 2013 · USPTO record
Lapsed on the fee recordEnded Apr 10, 2013USPTO record
US 7,494,652Treatment of sepsis
Formerly held
Lapsed on the fee record
Ended Feb 24, 2013 · USPTO record
Lapsed on the fee recordEnded Feb 24, 2013USPTO record
US 6,080,400Compositions for the prevention and treatment of verotoxin-induced disease
Formerly held
Lapsed on the fee record
Ended Jun 27, 2012 · USPTO record
Lapsed on the fee recordEnded Jun 27, 2012USPTO record
US 6,663,864Antibodies to cytokines in the prevention and treatment of inflammatory bowel disease
Formerly held
Lapsed on the fee record
Ended Dec 16, 2011 · USPTO record
Lapsed on the fee recordEnded Dec 16, 2011USPTO record
US 6,395,273Prevention and treatment of inflammatory bowel disease
Formerly held
Lapsed on the fee record
Ended May 28, 2010 · USPTO record
Lapsed on the fee recordEnded May 28, 2010USPTO record
US 6,346,247Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
Formerly held
Lapsed on the fee record
Ended Feb 12, 2010 · USPTO record
Lapsed on the fee recordEnded Feb 12, 2010USPTO record
US 6,613,329Vaccine and antitoxin for treatment and prevention of C. difficile disease
Formerly held
Term ended
Ended no later than Oct 31, 2009 · USPTO record
Term endedEnded no later than Oct 31, 2009USPTO record
US 6,046,165Compositions and methods for identifying and testing TGF-.beta. pathway agonists and antagonists
Formerly held
Lapsed on the fee record
Ended Apr 4, 2008 · USPTO record
Lapsed on the fee recordEnded Apr 4, 2008USPTO record
10 of 26 patents shown.
Pro members see all 26.
Pro members: see all 26 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited